Chinese Drug Manufacturer Reportedly Starts Producing Experimental Drug With Potential To Fight COVID-19

February 13, 2020

Bloomberg (2/12) reports BrightGene Bio-Medical Technology, a Chinese drug manufacturer, “has started mass-producing” Gilead Sciences’ experimental drug remdesivir, which “has the potential to fight the novel coronavirus.” The Chinese company “said in a s...